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Available online 27 November 2012Abstract Although progresses in developing differentiation procedures have been achieved, it remains challenging to
generate hES/iPS cell-derived mature hepatocytes. We performed knock-in of a monomeric Kusabira orange (mKO1) cassette in
the albumin (ALB) gene, in human embryonic stem (hES) cells and induced pluripotent stem (hiPS) cells, with the use of the
helper-dependent adenovirus vector (HDAdV). Upon induction into the hepatic lineages, these knock-in hES/iPS cells
differentiated into cells that displayed several known hepatic functions. The mKO1 knock-in (ALB/mKo1) hES/hiPS cells were
used to visualize hepatic differentiation in vitro. mKO1 reporter expression recapitulated endogenous ALB transcriptional
activity. ALB/mKo1 [Hi] population isolated by flow cytometry was confirmed to be enriched with ALB mRNA. Expression
profile analyses revealed that characteristic hepatocyte genes and genes related to drug metabolism and many aspects of liver
function were highly enriched in the ALB/mKo1 [Hi] population. Our data demonstrate that ALB/mKo1 knock-in hES/iPS cells
are valuable resources for monitoring in vitro hepatic differentiation, isolation and analyses of hES and hiPS cells-derived
hepatic cells that actively transcribing ALB. These knock-in hES/iPS cell lines could provide further insights into the mechanism
of hepatic differentiation and molecular signatures of the hepatic cells derived from hES/iPS cells.
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The liver plays a central role in multiple functions of the
human body including detoxification of drugs and storage
of nutrients. Animal models exhibit different metabolic
profiles from humans and are thus not directly applicable
to humans. Human primary hepatocytes are valuable for
assessing drug toxicity and testing drug kinetics (Davila et
al., 2004) but these applications are impeded from limited
availability and differences between samples. In addition
to their use in drug development, hepatocytes are
expected to be an alternative therapeutic approach for
producing transplantable hepatocytes since severe liver
dysfunctions are treatable only by liver transplantation in
many cases.
Embryonic stem (ES) cells are derived from the inner cell
mass of the fertilized egg, which is pluripotent, and can be
cultured indefinitely in an undifferentiated state and have the
potential to differentiate into various cell types derived from
the three germ layers (Evans and Kaufman, 1981; Kaufman et
al., 1983; Suemori et al., 2001; Thomson et al., 1998). Induced
pluripotent stem (iPS) cells (Takahashi and Yamanaka, 2006;
Takahashi et al., 2007, 2009; Belmonte et al., 2009) resemble
ES cells but raise fewer ethical concerns because they can be
derived from somatic cells. ES cells and iPS cells represent
powerful tools for studying basic developmental biology and are
potential sources of hepatocyte generation for applications in
regenerative medicine and drug development (Davila et al.,
2004).
ES and iPS cells have been shown to recapitulate
developmental processes and differentiate into hepatic
lineages in vitro following the sequential addition of growth
factors. Recently, human ES cells were directed to
differentiate in a stepwise manner into the definitive
endoderm, hepatic lineages, and hepatocytes following
the addition of Activin/Nodal, fibroblast growth factor
(FGF), BMP, retinoic acid (RA), Wnt3a and dimethyl
sulfoxide (DMSO), hepatocyte growth factor (HGF), and
oncostatin M (OSM) (Touboul et al., 2010; Shiraki et al.,
2008a, 2008b; Sullivan et al., 2010; Hay et al., 2008a,
2008b; Cai et al., 2007; Zaret and Grompe, 2008; Si et al.,
2010; Katsumoto et al., 2010).
We have previously established a procedure in which ES
cells are sequentially induced in vitro into the
mesendoderm, definitive endoderm, and regional specific
digestive organs such as the pancreas and liver (Shiraki et
al., 2008a, 2008b, 2009). Approximately 80% of the hES
that were cultured on a monolayer of the M15 mesonephric-
derived cell line and given growth factors differentiated
into α-fetoprotein (AFP)-positive hepatic precursor cells
and approximately 10% of cells later became albumin
(ALB)-positive cells and secreted a substantial level of
ALB protein (Shiraki et al., 2008b). Recently, we found
that optimization of the culture condition and culturing
cells on a synthesized basement membrane (sBM)
resulted in an improvement of ALB secretion (Shiraki et
al., 2011).
Modification of endogenous genes by homologous recom-
bination is well established and practiced in mouse ES cells.
However, although several reports have described gene
targeting by electroporation in hES cells (Zwaka and
Thomson, 2003; Urbach et al., 2004; Di et al., 2008; Rubyand Zheng, 2009; Sakurai et al., 2010), the efficiencies of
stable transfection (random integration) were extremely low
(approximately 1×10−6 per cell) and the ratio of targeted to
random chromosomal integration was also low (approximately
2%). In contrast, the helper-dependent adenovirus vector
(HDAdV) was a reportedly efficient and versatile gene
targeting vector in mouse ES cells and allowed the insertion
of a long homologous sequence of up to 35 kb (Ohbayashi et
al., 2005). HDAdV was originally developed to overcome host
immune responses against E1D AdVs in vivo (Palmer and Ng,
2005). Because all of the viral genes are removed from the
vector genome, HDAdVs offer additional advantages such as
decreased cytotoxicity and expanded cloning capacity,
permitting insertion of longer segments of homologous
DNA for homologous recombination. These features are
advantageous for obtaining highly efficient site-specific
integration into host chromosomes through homologous
recombination. The HDAdV system was shown to be a
powerful tool for genetic manipulation in hES and human
iPS (hiPS) cells. When HDAdVs were used to target several
loci, the recombination efficiencies were 3–55% (Suzuki et
al., 2008; Aizawa et al., 2012). Recently, targeted gene
correction in patient-specific iPS cells was reported using
HDAdVs (Liu et al., 2011; Li et al., 2011). Taken together,
gene transfer mediated by HDAdVs is a powerful technology
for genetic manipulation in hES and hiPS, both for biological
studies and therapeutic applications.
Herein, to trace the differentiation and analyze human ES
or iPS cell-derived hepatocytes, we carried out gene targeting
of a reporter transgene to the ALB locus and established ALB/
monomeric Kusabira orange1 (mKO1) knock-in (ALB/mKo1)
hES and hiPS cell lines, and report here the use of these
knock-in hES and hiPS cell lines, cultured under a modified
version of our previously established differentiation procedure
(Shiraki et al., 2008b).
Material and methods
Construction of the ALB/mKo1 bacterial artificial
chromosome (BAC) clone and the pHDAdV ALB/
mKo1-PGKneo vector
The human BAC clone RP11-281P16 contains the human ALB
gene locus from the RPCI-11 Human Male BAC Library
(Osoegawa et al., 2001) and was purchased from BACPAC
Resources. The BAC-based targeting vector was generated by
a 2-step recombineering modification (Copeland et al., 2001).
First, the zeocin resistance gene (p23-loxP-Zeo) was targeted
into the loxP site of the human ALB BAC clone RP11-281P16
(BACPAC Resources). The mKO1 reporter cassette, pKS-
mKO1-loxP-Neo-loxP, was constructed using mKO1 cDNA
from pmKO1-MC1 (Medical & Biological Laboratories)
(Karasawa et al., 2004). Homology arms were then inserted
on the 5′ and 3′ ends of the cassettes to generate
pKS-hALB-Larm-mKO1-loxP-PGK-EM7-Neo-loxP-Rarm. Second
targeting; mKO1-PGK-EM7-Neo was then targeted into the
ATG site of ALB exon 1 of RP11-281P16 to generate BAC-ALB/
mKo1-loxP-Neo (Supplementary Fig. 1). A 23-kb fragment
from the BAC-ALB/mKo1-loxP-Neo vector, which included
101,721–124,538 bp of RP11-281P16 and the reporter
fragment, was retrieved into pBC-HDAdTKβgal1-PISceI by
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Figure 1 Gene targeting at the ALB locus in human ES/iPS cells. The strategy of gene targeting and analysis of targeted clones are
shown. (A) Structure of the human ALB locus, the HDAdV ALB/mKo1-PGK-Neo targeting vector, and the targeted locus. ALB exons
(gray boxes indicate exons 1–10) and the homology in the targeting vector are indicated by a thick line. Elements in the targeting
vector include mKO1 cDNA, PGK-Neo cassette, HSVtk, and β-gal genes. BamHI (B) and BsrBI (Bs) sites are indicated. Probes a, b, and c
indicate the 5′ probe, the mKO1 cDNA probe, and the 3′ probe used for Southern blot analysis, respectively. (B) Southern blot analysis
of BamHI- and BsrBI-digested genomic DNA. ALB/mKo1 #5, #12, and #15 hES cells are shown in the upper panels. ALB/mKo1 [10, 24],
#20, #21, and #24 hiPS cells are shown in the lower panels. Results with the 5′ probe, 3′ probe, and mKO1 probe are shown. (C) Gene
targeting efficiencies at ALB locus in hES cells and iPS cells are indicated. GT, gene targeting; GANC, ganciclovir.
181ALB/mKo1 knock-in hiPS and hES cellshomologous recombination in E. coli (Supplementary Fig. 1).
The resultant vector was named as pBC-HDAdVALB/
mKo1-PGKneo. A detailed subcloning description can be
provided on request.Production and purification of HDAdVs
pBC-HDAdV ALB/mKo1-PGKneo was linearized by PI-SceI
(New England Biolabs) and transfected into 293FLPe cells in
cultured with mouse embryonic fibroblast (MEF)-conditioned
182 K. Umeda et al.the presence of helper virus, FL helper (kindly provided by Dr.
Lowenstein; Umana P). The rescued vectors were propagated
by serial passages on 293FLPe cells with the addition of FL
helper, as described previously (Umana et al., 2001). HDAdV
DNA derived from pHDAdV ALB/mKo1-PGKneo was packaged
into virus particles with the Ad5 fiber.A
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183ALB/mKo1 knock-in hiPS and hES cellsmedium. On day 2, the culture medium was replaced by 1 ml
of Dulbecco's modified Eagle's medium (DMEM)/F12 (Sigma-
Aldrich) and the cells were counted and infected with the ALB
targeting vectors at a multiplicity of infection of 1000 vector
genomes/cell, which was determined by quantitative South-
ern analysis. Infection was performed for 1 h at room
temperature and 8 ml of MEF-conditioned medium was
added. G418 selection (50 μg/ml; Nacalai Tesque) was
started 2 days after infection. After 3 weeks, surviving
colonies were transferred to 96-well plates and GANC
selection (2 μM, Invitrogen) was started. After 7 days,
G418 and GANC double-resistant clones were characterized
by Southern blot analysis.
Human ESand iPS cell lines
The hESC line KhES-3 (Suemori et al., 2006) (a gift from Dr.
Nakatsuji, Kyoto University, Kyoto, Japan) and the hiPSC line
246H1 (Aizawa et al., 2012) (a gift from Dr. Yamanaka in Kyoto
University, Kyoto, Japan) were used for the establishment of
ALB/mKo1 knock-in cell lines. Human ES cells were used in
accordance with the human ES cell guidelines of the Japanese
government. This human ES cell work was approved by the
Kumamoto University Institutional Review Board.
Undifferentiated hES and hiPS cells were maintained on a
feeder layer of MEF in Knockout DMEM/F12 (Sigma-Aldrich)
supplemented with 20% Knockout Serum Replacement (KSR;
Invitrogen), 2 mM L-glutamine (L-Gln; Nacalai Tesque),
0.1 mM nonessential amino acids (NEAA; Invitrogen), 0.1 mM
β-mercaptoethanol (ME), 50 U/ml penicillin and 50 mg/ml
streptomycin (PS; Nacalai Tesque), 5 ng/ml bFGF (Peprotech)
under 3% CO2. To passage hES/iPS cells, cells were detached
from the feeder layer with 0.25% trypsin and 0.1 mg/ml
collagenase IV in PBS containing 20% KSR and 1 mM CaCl2 at
37 ºC for 6 min followed by the addition of culture medium
and the disaggregation of ES/iPS clumps into smaller pieces
(5–20 cells) by a cell scraper.
Immunocytochemistry
To examine the undifferentiated state of ALB-targeted hES
and hiPS cells, the expression of Alkaline phosphatase (ALP)
and surface markers (SSEA-4, TRA1-60, and TRA1-81) was
examined by immunocytochemical staining with the ES cell
characterization kit (Chemicon) following the manufacturer's
protocol. The expression of Oct-3/4 was examined by immuno-
cytochemical staining using the anti-OCT4 antibody (Santa Cruz
Biotechnology). For immunocytochemical analyses of Sox17,
ALB, and AFP, goat anti human Sox17 (R&D Systems), goatFigure 2 Differentiation of human ALB/mKo1 hES and iPS cells int
be able to differentiate into hepatic lineages showing several aspec
#12 hES cells, #24 hiPS cells, and 246H1 hiPS cells were differentia
246H1 wild type hiPS cells were used as control. A definitive endode
and ALB was first observed at d20 and increased thereafter. AFP a
antibody and the Alexa 488-conjugated antibody, respectively. The
efficiency of ALB/mKo1 #12 hES cells. Proportion of cells expressing
system (N=3) at the indicated days. (C) ICG-positive cells and PAS st
d30. KhES3 (wild type) hES cells were used as control. (D) ALB secre
d30. Error bars indicate the standard error of the mean (SEM). N=3
differentiated ALB/mKo1 #5 and #12 hES cells and #20, #21, and #24anti-human ALB (Sigma-Aldrich) and rabbit anti-human AFP
(Dako Cytomation) were used. Alexa 568-conjugated, Alexa
488-conjugated, or Alexa 633-conjugated (Molecular Probes)
secondary antibodies were used. To allow co-detection with
mKO1, the expression levels of AFP and ALB were visualized by
the Alexa 633-conjugated antibody for AFP or the Alexa 488-
conjugated antibody for ALB. Cells were counterstained with
6-diamidino-2-phenylindole (DAPI) (Roche Diagnostics).
Teratoma formation
ALB-targeted hES and hiPS cells were injected subcutane-
ously (s.c.) into SCID mice (CLEA Japan) at an approximate
total of 1×107 cells per clone. After 2–3 months, the
resulting teratomas were recovered, fixed, and stained
with hematoxylin and eosin.
Hepatic differentiation of human ES and iPS cells
For differentiation studies, hES and hiPS cells were seeded in
24-well plates pre-plated with M15 cells and cultured in
differentiation medium. For days 0–10 of differentiation, RPMI
1640 medium (Invitrogen) supplemented with L-Gln, PS, NEAA,
β-ME, 2% (v/v) B27 supplement (Invitrogen) and Activin A
(100 ng/ml) was used. For differentiation from d10 to the
indicated day, DMEM supplementedwith L-Gln, PS, NEAA,β-ME,
10% KSR, 2000 mg/ml glucose, 1 μM dexamethasone (Dex;
Sigma-Aldrich), and 10 ng/ml recombinant human hepatocyte
growth factor (HGF, Peprotech) was used. The medium was
replaced every 2 days.
Quantitative imaging analysis
Differentiated cells were assayed by immunostaining. Fluo-
rescent images of Sox17, AFP and ALB expression and mKO1
fluorescence were quantified using a ImageXpress Micro
scanning system and MetaXpress cellular image analysis
software (Molecular Devices). Positive cells were counted
and percentages were calculated versus total cell number,
by counting DAPI stainings.
Semi-quantitative reverse-transcription polymerase
chain reaction (RT-PCR) and real-time PCR analysis
RNA was extracted using the RNeasy Mini-Kit and the RNeasy
Micro-Kit (Qiagen) followed by treatment with DNase I
(Sigma-Aldrich). Human adult liver total RNA were purchased
from Clontech Laboratories, Inc. RNA (3 μg) was reverse-o hepatic lineages. Knock-in hES and iPS cells were confirmed to
ts of hepatocyte functions and expressed mKO1. (A) ALB/mKo1
ted into the definitive endoderm followed by hepatic lineages.
rm marker, Sox 17, was expressed at d10. The expression of AFP
nd ALB expression was visualized by the Alexa 633-conjugated
scale bars represent 100 μm in all panels. (B) Differentiation
the indicated marker counted and calculated by image scanning
aining of Kh3ES and ALB/mKo1#12 hES cells and #24 hiPS cells on
tion by Kh3 ES and ALB/mKo1 #12hES cells and #24 iPS cells on
. KhES3 cells were used as control. (E) Fluorescence images of
hiPS cells at the indicated days are shown. Scale bars, 100 μm.
184 K. Umeda et al.transcribed using ReverTraAce (Toyobo) and oligo dT primers
(Toyobo). PCR analysis was performed as described (Shiraki et
al., 2008b, 2011). For semiquantitative PCR, KOD dash
polymerase (Toyobo) was used for detection of glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) and Amplitaq Gold
fast premix (Applied Biosystems) was used for detection of the
other genes. cDNA amounts and cycle numbers were opti-
mized for detection in a linear range. The primer sequences
and numbers of cycles are listed in Supplementary Table 5.
The PCR conditions for each cycle were as follows:
denaturation at 96 °C for 30 s, annealing at 60 °C for 2 s,
extension at 72 °C for 45 s (Kod Dash polymerase) or
denaturation at 96 °C for 3 s, annealing at 68 °C for 15 s,
and extension at 72 °C for 45 s (Amplitaq Gold fast premix).
For real-time PCR analysis, the mRNA expression was
quantified with SyberGreen on an ABI 7500 thermal cycler
(Applied Biosystems, Foster City, CA). The level of each gene
expression was normalized with that of GAPDH. The PCR
conditions were as follows: denaturation at 95 °C for 15 s,
annealing and extention at 60 °C for 60 s, for up to 40 cycles.
Target mRNA levels were expressed as arbitrary units, and
were determined using the standard curve method.
ALB secretion assay
The culture medium was replaced with fresh medium 1 day
before the assay. Conditioned medium was harvested 24 h
later and assayed for ALB secretion using an enzyme-linked
immunosorbent assay (ELISA) kit (Bethyl, Montgomery, TX).
Albumin secretion levels were normalized to the total
protein of differentiated ES cells at each sampling point.
The protein amounts were calculated using the Bio Rad
Protein Assay Kit (Bio Rad, Hercules CA). Briefly, frozen
hepatocytes obtained from Invitrogen were thawed and
cultured for 24 h on collagen I-coated plates with hepato-
cyte maintenance medium (Invitrogen) and were subjected
to the ALB secretion assay.
Indocyanine green (ICG) test
ICG (Daiichi-Sankyo Pharma, Tokyo, Japan) was diluted in the
above culture medium to a final concentration of 1 mg/ml.
The ICG test solution was added to the differentiated ES/iPS
cells on D30, and incubated at 37 °C for 30 min. Cells were
washed three times with PBS, and the cellular uptake of ICG
was then examined by microscopy.
Periodic acid Schiff (PAS) analysis
The cultured cells were fixed in 3.3% formalin for 10 mins,
and intracellular glycogen was stained using a PAS staining
solution (Muto Pure Chemicals, Tokyo, JAPAN), according to
the manufacturer's instructions.
Microscopic observation of mKO1 fluorescence
mKO1 fluorescence was detected with an excitation 546/
11 nm band pass filter and the emission signal was obtained
using a 555-nm-long pass dichroic mirror and a 575/30 nm
band pass filter.Flow cytometry analysis
Hoechst blue was used to verify living cells. Hoechst blue
was detected with an excitation of 355 nm and detection
with a 450/50 nm band pass filter. mKO1 fluorescence was
analyzed with an excitation of 488 nm and detection with a
575/25 nm band pass filter. Cells were analyzed with a FACS
Canto (Beckton, Dickinson and Company; BD) or purified
with FACS Aria II (BD). Data were recorded with the BD
FACSDiva Software program (BD) and analyzed using the
FlowJo program (Tree Star).Microarray analysis
Biotinylated cRNAs were prepared using the Gene CHIP 3′ IVT
Express Kit (Affymetrix) from 50 ng of total RNA purified from
ES cells on differentiation day 25 (d25) ALB/mKo1 negative [−],
low positive [Lo], and high positive [Hi] fractions were
hybridized with Human Genome U133 Plus 2.0 GeneChip arrays
(Affymetrix).
All probe sets were normalized by using the MAS5.0
statistical algorithm on the Affymetrix Expression Console.
Microarray results including raw signal intensities and
detection calls, and adult liver data from GSM561873 of
the Gene Expression Omnibus were imported into the Subio
platform (Subio Inc., Japan). The intensities of the full probe
sets were log2 transformed and subsequently we extracted
the probe sets that were present in mKo1 [Hi] populations
and whose signal intensity was more than 100 in mKO1 [Hi]
populations.
Up-regulated probe sets were selected in ALB/mKo1 [Hi] if
their [Hi]/[−] ratio showed a change more than 10-fold.
Enrichment analysis by pathway was performed with all the
up-regulated probe sets to identify within which specific
cellular pathways these probe sets are mapped. Pathways
with pb0.05 were considered significantly enriched. Enrich-
ment analysis by Gene Ontology (GO) biological process terms
was performed to identify specific GO terms that showed
enrichment for the up-regulated probe sets. GO terms related
to liver function were selected. A list of genes up-regulated in
the ALB/mKo1 [Hi] population [Hi]/[−]≥10 was entered into a
Mouse Genome Informatics (MGI) batch query, and associated
alleles and phenotypes of mutant mice were retrieved; the
genes associated with the mutant mice that showed the liver/
hepatocyte-related phenotype were extracted.
To identify drug metabolism-related genes, probe sets
after filtering by detection calls and raw signal intensity,
were applied to the digestive system bile secretion Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway. Those
probes that showed more than two-fold increase in ALB/
mKo1 [Hi] compared to the ALB/mKo1 [−] population were
extracted, and a heat map was generated.
To identify genes that are liver specific and/or related to
liver development or maturation, the remaining genes that
were not described in the above analyses were entered into
the HG-U133 Plus 2.0 Sample Dataset from liver and various
tissues (http://www.affymetrix.com/support/technical/
sample_data/exon_array_data.affx) and GSE15238 of the
Gene Expression Omnibus, consisting data sets from various
stages of human liver samples (9–12 weeks fetal liver, 1-, 42-
and 81-year old postnatal liver and 10 weeks whole embryo
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Figure 3 The onset of mKO1 expression coincides with ALB expression in ALB/mKo1-targeted hES and hiPS cells upon hepatic
differentiation. (A) mKO1 (green) and ALB (red) expression are fist observed in ALB/mKo1 #12 hES cells on differentiation d20 and
increased on d25, detected by immunocytochemistry. Open triangle depictsmKO1positive cell. Scale bar, 100 μm. (B, C) Time-dependent
expression of mKO1 (B) coincides with that of ALB (C) on d20 and d25, detected by RT-PCR. Scale bars, 100 μm. Blue: DAPI
counter-staining. (D) Merged images ofmKO1 (green), anti-ALB (red), andDAPI (blue) in ALB/mKo1 #5 hES on d37, #12 hES cells on d30, #21
hiPS cells on d34 and #24 on d31. (E) Proportions of ALB-positive ormKO1-positive cells in total differentiated cells. ALB single positive cells
within ALB-positive cells in ALB/mKo1 #5 hES, #12 hES, #21 hiPS and #24 hiPS cells were calculated by image scanning. Scale bars, 150 μm.
185ALB/mKo1 knock-in hiPS and hES cellsexcluding the liver). Genes differentially expressed among
embryonic liver samples and postnatal liver sampleswithmore
than 5-fold changes (with significance pb0.05) were selected.
Metabolic zonation related genes (Benhamouche et al.,
2006; Torre et al., 2011) were identified from probe sets that
were present in ALB/mKo1 [Hi] populations and whose signal
intensity was more than 100 ALB-in mKo1 [Hi] populations andshowedmore than two-fold increase or decrease in ALB/mKo1
[Hi] compared to the ALB/mKo1 [−] population and a heatmap
was generated.
Data from human ES cells H9 and HNF4A knock-down H9
cells (GSE14897 and GSE25417 from GEO) (Si-Tayeb et al.,
2010; DeLaForest et al., 2011), or AFP:eGFP-positive cells
(Human Exon 1.0 ST Array)(Chiao et al, 2008) were used for
186 K. Umeda et al.comparison. The list of gene symbols of 609 genes (Chiao et
al., 2008) was entered into our microarray data and 584 genes
were retrieved and 507 genes were present in ALB/mKo1 Hi
population.
Results
Gene targeting at the ALB locus in human
ES/iPS cells
To perform knock-in of the reporter mKO1 cDNA under the
ALB gene promoter, we constructed an ALB/mKo1-targetingC
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187ALB/mKo1 knock-in hiPS and hES cellsinfected with the HDAdV ALB/mKo1-PGKneo vector, which
was packaged in viral particles.
After sequential positive selection with G418 and negative
selection with GANC, drug-resistant clones were analyzed and
gene-targeted clones were determined. The genomic struc-
ture of the human ALB gene is shown in Fig. 1A. Southern blot
analysis was performed to confirm that the ALB locus was
targeted (Fig. 1B). Southern blot showed that the wild-type
ALB allele displayed a 35.0-kb band on Southern blotting of
BamHI-BsrBI digested DNA using the 5′ or 3′ probe (Fig. 1A,
probes a and c, respectively). The ALB/mKo1 locus showed a
25.3-kb band with the 5′ probe and a 11.5-kb band with the 3′
probe (Fig. 1B). Furthermore, a 25.3-kb band (Fig. 1A, probe
b) was detected with themKO1 probe in the knock-in cell lines
(Fig. 1B). Although the slightly fast migration profile of the
#5hES clone might have been due to a difference in DNA
amount and/or the long running distance and the high
magnification of the gel, the possibility that deletion of
small fragments occurred cannot be excluded. Of the G418-
resistant 16 hES and 17 hiPS clones examined, 10 and 6 clones
were GANC-resistant, of which, 9 and 5 independent clones
were confirmed by southern blot analysis to have undergone a
single homologous recombination event, respectively. There-
fore, gene-targeting frequencies per drug-resistant colony
(GANC and G418) were 90% for hES cells and 83% for hiPS cells
(Fig. 1C).
The undifferentiated state and pluripotencies of the ALB/
mKo1 knock-in cells were confirmed by their alkaline
phosphatase (ALP) activities and expressions of stem cell
markers such as Oct3/4, SSEA-4, TRA1-60, and TRA1-81, and
teratoma formations (Supplementary Fig. 2).Monitoring ALB/mKo1 knock-in hES/iPS cell
differentiation into hepatic lineagesWe first optimized the differentiation protocol. #12 hES and
#24 hiPS cells were seeded on M15 cells and hepatic
differentiation was induced, respectively. Wild-type
246H1 hiPS cells were used as a control. We added Activin
A and 2% B27 in RPMI 1640 medium and cultured for 10 days
to induce differentiation into the definitive endoderm and
then added dexamethasone and HGF, 10% KSR in DMEM toFigure 4 Isolation and characterization of ALB/mKo1-positive ce
cytometry. We confirmed that cells expressed a high level of mKO1 (
characterize the adult hepatocytes. (A) Bright field (BF) and fluoresc
25 days. Scale bars, 100 μm. (B) The differentiated #12 hES cells wer
(X-axis). Numbers in parentheses indicate the proportions of mKO1-p
low positive [Lo], and highly positive [Hi] populations were colle
undifferentiated ES cells (ES), mKO1 [−], [Lo], [Hi], to detectmKO1 an
of the gene expression profiling analysis procedure. After filtering, the
population as compared to the [−] population were selected, and appl
phenotype and enrichment analysis. Drug metabolism related genes i
were extracted from the probe sets with [Hi]/[−]≥2. The numbers of
map generated by the Subio platform of the 46 representative gen
iii) phenotype search, and iv) known hepatocyte markers. The sam
[Hi], and human Adult liver (AL) from GSM561873 of the Gene E
indicates low expression. The numbers under the color bar indicapromote hepatic differentiation. We found that our present
modified protocol gave a higher proportion of SOX17-
expressing endoderm, and was more efficient in yielding
higher levels of ALB transcripts compared to our previous
culture condition (Shiraki et al., 2008b) (Supplementary
Fig. 3).
Under the modified protocol, immunocytochemical analy-
sis revealed that 246H1 parental cells displayed monolayer
morphologies and expressed SOX17 on day 10 (d10) (Fig. 2A).
On d20 of differentiation, where most cells were AFP-positive,
ALB-positive cells began to appear. ALB expression increased
on d25 and further accumulated on d30 (Fig. 2A). Similar
time-dependent staining patternswere observed in ALB/mKo1
#12 hES and #24 iPS cells (Fig. 2A, upper andmiddle panels). In
ALB/mKo1 #12 hES, SOX17-positive cells were 76.7±0.1 on
d10, AFP-positive cells were 67.2±0.5% on d20 and ALB-
positive cells were 43.3±1.3% on d25 (Fig. 2B). These #12 hES
or #24 hiPS cell-derived hepatic cells incorporated
indocyanine green (ICG) and were positive for periodic
acid-Schiff (PAS), which indicated cytoplasmic glycogen
storage (Fig. 2C). Moreover, the secreted ALB proteins were
between the range of 408–1048 ng day−1·mg·protein−1
detected on d30, approximately half of that of the primary
hepatocytes (1865 ng day−1·mg·protein−1; NS, unpublished)
(Fig. 2D).
The above results demonstrated that the targeted hES/
iPS cells were successfully differentiated into hepatic cells
displaying hepatic functions. We then examined the mKO1
fluorescence of these mKO1 targeted hES/iPS clones.
ALB/mKo1 #5 and #12 hES cells and #20, #21 and #24 hiPS
cells showed a substantial level of mKO1 fluorescence
after directed for hepatic differentiation on d30–d34
(Fig. 2E).
The time-dependent mKO1 fluorescence of ALB/mKo1 #12
hES appeared from d20, and increased thereafter, and 18.3±
1.96% of total cells became mKO1-positive on d25 (Fig. 3A,
upper panels). ALB protein was detectable on d20 and
continued to increase, with many positive cells on d25
(Fig. 3A). The mKO1 transcript findings revealed by quantita-
tive RT-PCR were consistent with the mKO1 fluorescence,
which was low on d20 and increased on d25 (Fig. 3B). ALB
mRNA also increased from d20 to d25 (Fig. 3C). mKO1
expression merged with ALB expression. We then compared
with other hES/iPS clones (Fig. 3D). We counted thells. Differentiated cells expressing mKO1 are isolated by flow
ALB/mKo1 [Hi]) also highly expressed ALB mRNA, and genes that
ent images (mKO1) of ALB/mKo1 #12 hES cells differentiated for
e analyzed by flow cytometry for mKO1 (Y-axis) and Hoechst blue
ositive cells within the total ES cell culture. mKO1 negative [−],
cted. (C) Semiquantitative RT-PCR analysis was performed in
d ALB transcripts. GAPDH served as a positive control. (D) Scheme
probe sets with more than- 10-fold increase in the ALB/mKo1 [Hi]
ied to survey for genes associated with mutant mice with the liver
nvolved in the digestive system bile secretion pathway of KEGGs
selected probes or genes in each step are indicated. (E) The heat
es obtained from i) enrichment analysis, ii) GO term analysis,
ples shown in the columns represent ALB/mKo1 [−], [Lo], and
xpression Omnibus. Red indicates high expression and green
te log2 transformed signal intensity.
188 K. Umeda et al.percentages of the ALB- or mKO1-positive cells using an image
scanning system and found that approximately 23.5–26.7% of
total cells were positive for mKO1 fluorescence, whereas
approximately 36.5–55.1% were positive for ALB (Fig. 3E). In
all clones, we found that all the mKO1-expressing cells were
also ALB-positive, and that no mKO1-single positive cells were
observed, although 34.0–54.1% of ALB-positive cells (approx-
imately 12.8–30.9% of total cells) were ALB-single positive
(Fig. 3E).
Isolation and characterization of ALB/mKo1-positive
cells
To confirm that the mKO1-positive cells represented
ALB-positive cells, ALB/mKo1 #12 hES cells were harvested
on d25 of differentiation (Fig. 4A) and analyzed by flow
cytometry. ALB/mKo1-positive cells were fractionated by
signal intensities of mKo1 fluorescence into the following 3
populations: ALB/mKo1-negative ([−], 68.7%), mKO1 low
positive ([Lo], 16.1%), and mKO1 high positive ([Hi], 12.3%)
cells (Fig. 4B). The sum of mKO1-positive [Hi] and [Lo]
population, being accounted to 28.4% by flow cytometry,
was slightly higher than that of the mKO1-positive cells
accounted by microscopic observation of the fixed cells on
d25 (18.3±1.96%; Fig. 3A). Semiquantitative RT-PCR analysis
indicated that the mKO1 transcript was detected as a strong
band in the ALB/mKo1 [Hi] population but was faint in the
ALB/mKo1 [Lo] population (Fig. 4C). Therefore, we conclud-
ed that ALB transcript expression correlated with mKO1
fluorescence intensity: a higher level of ALB transcript was
expressed in mKO1 [Hi], and a lower level of ALB transcript
was expressed in the mKO1 [Lo] population (Figs. 4B, C), and
that ALB/mKo1 cells represent cells actively transcribing
ALB.
Gene expression profiling analyses
We subsequently sorted ALB/mKo1-positive cells and
performed gene expression profiling analysis of ALB/mKo1
[−], [Lo], and [Hi] populations (Figs. 4D, E). The following
i)–v) analyses were performed for probe sets: i)–iv) with
≥10 fold increase ([Hi]/[−]≥10; 230 genes), iv) partially
with ≥3 fold ([Hi]/[−]≥3), and v) with ≥2 fold increases
([Hi]/[−]≥2).
i) Enrichment analysis by pathway
Enrichment analysis identified 5 pathways (28 probes or
19 genes) significantly enriched in the ALB/mKo1 [Hi]
population including the statin pathway, angiotensin-
converting enzyme (ACE) inhibitors, blood clotting
cascade, glycolysis and glycogenesis pathway, and
irinotecan pathway (Supplementary Table 1).
ii) Enrichment analysis by GO term and selection of
liver-related genes
From enrichment analysis by GO term, we then
extracted 39 probe sets (31 genes) that are related to
liver function. These consisted of genes that are related
to lipid metabolism and transport, cellular iron ion
homeostasis, the acute-phase reaction, complement
activation, and fibrinolysis (Supplementary Table 2).
iii) Other liver related or genes with liver phenotypes in
their mutant miceThirty-three genes reportedly associated with mutant
mice showing hepatocyte/liver-related phenotypes were
retrieved from MGI database. Among these genes, 16
genes are shown in Supplementary Tables 1 and 2. The
remaining 17 genes that showed phenotypes in mutant
mice, together with hepatocyte markers Cytochrome
P4503A7 (Cyp3A7), tryptophan 2,3-dioxygenase (TDO2),
asialoglycoprotein receptor (ASGR), and transthyretin
(TTR) that were not reported with liver phenotypes, are
shown in Supplementary Table 3.
From the above mentioned genes, 46 representative
genes were used to generate a heat map using the Subio
program (Fig. 4E).
iv) Genes differentially or constitutively expressed during
liver developmental and after birth
We then analyzed the remaining 160 genes (referred as
‘other genes’, Fig. 4D), and compared with data sets
(GSE15238 of the Gene Expression Omnibus) from early
stages of human liver development (9–12 weeks human
embryonic livers) and postnatal livers (1, 42, 81 years)
andwith HG-U133 Plus 2.0 Sample Dataset from liver and
various tissues (http://www.affymetrix.com/support/
technical/sample_data/exon_array_data.affx).
Thirty genes that are differentially expressed during
liver developmental stages are listed in Supplemen-
tary Fig. 4. Of these genes, 14 were absent in the
embryonic livers, but increased later in the adult
liver, and were enriched in ALB/mKo1[Hi] population
with ≥3-fold increase (ALB/mKo1[Hi]/[−]≥3) (Sup-
plementary Table 4). We actually confirmed that
ZG16 and CHST9 are specifically expressed in the adult
liver (K.U. unpublished). Thirty-nine genes that are
expressed throughout developmental stages of liver are
shown in Supplementary Fig. 5. Of these genes, genes
specifically expressed in the liver are listed in red letters.
v) Drug metabolism-related genes
From probe sets that were up-regulated ≥two-fold in
the ALB/mKo1 [Hi] compared to the ALB/mKo1 [−]
population ([Hi]/[−]≥2), important genes for hepatic
drug metabolism were extracted (32 probe sets or 23
genes, Supplementary Table 5). A heat map of 21 genes
that are expressed in the hepatocyte was generated to
compare with those of the adult liver (Fig. 5). Enzymes
involved in phase I metabolism (bile acid synthesis and
detoxification), phase II metabolism (conjugation) or
sinusoidal transporters (efflux or uptake), and bile
canalicular transporters were enriched.
We then confirmed the gene expression profiles with
other clones (Fig. 6). We found that ALB/mKo1#5 hES
cells were less potent and ALB/mKo1-positive cells
began to appear on d25. Therefore, we considered
ALB/mKo1#5 hES d35 to be comparable with d25
#12hES, and #24hiPS d34 be comparable with #12
hiPS d34. We fractionated ALB/mKo1 [Hi], [Lo] and
[−] populations by flow cytometry from ALB/mKo1 #5
hES (d35) and #24hiPS (d34) and compared with #12
hES d25 and d34 (Figs. 6B, C). Representative genes
identified in the above microarray analyses were picked
up and their expressions were confirmed by semi-
quantitative RT-PCR analyses. All genes examined
were expressed at a much higher level in ALB/mKo1
[Hi] compared to [−] population. Taken together, we
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189ALB/mKo1 knock-in hiPS and hES cellsconcluded that similar enrichments of the mature
functional hepatocyte genes are observed in all ALB/
mKo1 [Hi] populations of the hES/iPS clones so far
examined.
Discussion
HDAdV achieved highly efficient gene targeting for
ALB/mKo1 in human ES and iPS cells
Homologous recombination has been used widely in mouse
ES cells and has contributed to biological studies, but
significant efficiency differences betweenmice and humans
have hampered its application to hES cells (Thomas and
Capecchi, 1987). Presently, several reports have described
alternative gene modification in hES by homologousrecombination and the reported efficiency by conventional
electroporation method is low in both hES and hiPS cells
(0.14–0.24%) (Zwaka and Thomson, 2003; Zou et al., 2009).
We previously reported that the HDAdV system is a powerful
tool for genetic manipulation of hES/iPS cells other than
mouse ES cells (Suzuki et al., 2008; Aizawa et al., 2012). In
our previous report with the HDAdV system, chromosomal
integration efficiency of the hypoxanthine phosphoribosyl
transferase1 (HPRT1) was ~5.6×10−5/cell and gene targeting/
chromosomal integration was 3–55% in hES cells whereas
chromosomal integration efficiency by use of the same
vector was 1.6×10−6/cell and gene targeting/chromosomal
random integration was ~0.58% in the case of electropora-
tion. In this report, the targeting/chromosomal integration
ratio was as high as 56% for hES and 29% for hiPS cells. When
combined with negative selection, the frequencies were
enriched up to 90% for hES cells and 83% for hiPS cells
190 K. Umeda et al.(Fig. 1C). Our results thus demonstrate that HDAdVs is a
powerful technology for gene targeting in human ES/iPS
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191ALB/mKo1 knock-in hiPS and hES cellsa transducing lentivirus vector containing a green fluorescent
protein (GFP) reporter driven under the α1-antitrypsin (AAT or
SERPIN A1) promoter (Duan et al., 2007) or enhanced GFP
driven by the AFP promoter (Chiao et al., 2008). Since random
integration occurs in the lentivirus vector system, the fidelity
of the expression pattern of the transgene required to be
confirmed if they recapitulate endogenous gene expression
pattern. In contrast, our HDAdV system provides a highly
efficient method for targeting the gene of interest by
homologous recombination, in which the reporter genes
consistently follow the endogenous promoter activity. Further-
more, compared to the ALB gene, which is tissue specifically
expressed in the liver, the AAT gene is also expressed in the
lung (Carlson et al., 1988).Hepatic differentiation of the hES/iPS cells
We induced hepatic differentiation of hiPS and hES cells
using a previously established M15 procedure with modifica-
tions to the culture medium. We observed higher proportions
of SOX17-positive cells and much higher levels of AFP and ALB
transcripts and mKO1 fluorescence, compared to our previ-
ously described culture condition (Shiraki et al., 2008b)
(Supplementary Fig. 3). Under the modified protocol, the
mKO1 fluorescence became detectable from around d20 and
increased to a substantial level on d25 (Fig. 3A), whereas it
was not until d30–d34 that the mKO1 fluorescence became
detectable under the previous condition (data not shown).
Under the modified culture condition, the ALB/mKo1 knock-in
hiPS and hES cells differentiated into hepatic fates in vitro and
yielded approximately 67.2% AFP-positive cells at d20 and
51.5% ALB-positive cells at d30 (Fig. 2B). These cells secreted
ALB protein (Fig. 2D) at a level approximately one-fourth to
one-half of that of the cultured human primary hepatocytes
(at 1865 ng day−1·mg·protein−1; NS, unpublished) and showed
ICG intake and positive for PAS (Fig. 2C).
Differentiated cells with mKO1 fluorescence were ob-
served from d20 and increased on d25, which correlated
with the increase of mKO1 transcript. ALB transcripts and
ALB protein were also detected from d20 (Fig. 3). Therefore,
the onset of mKO1 and ALB expression coincided with each
other in a time dependent manner. All the mKO1-positive
cells co-expressed ALB protein and no mKO1-single positive
cells were observed. However, there were ALB-single
positive cells in all hES/iPS clones. This discrepancy between
the mKO1- and ALB-expressing cells might due to the
differences in protein stability between mKO1 and ALB.
The half-life reported for native ALB protein is 19 days
(Torre et al., 2011), which is much longer than that reported
with the green fluorescence protein (GFP) as approximately
24 h (Li et al., 1998). Given that it is difficult to maintain
functional hepatocytes in vitro in long term cultures. ALB
transcriptional activities might change coordinately with the
hepatocyte activities. The extended stability of the ALBFigure 6 Examination of gene expressions in other ALB/mKo1 clon
expressions in ALB/mKo1 [Hi], [Lo] and [−] populations from ALB/mK
cells. (A) Time dependent mKO1 fluorescence observed in ALB/mKo1
(B, C) The differentiated cells were analyzed by flow cytometry for
proportions of mKO1-positive cells within the total ES cell culture.
populations were collected. (D) Semi-quantitative RT-PCR analyses w
[Hi], to detect representative enriched genes from microarray resulprotein then results in a prolonged ALB protein accumulation
in cells with low ALB transcriptional activities.Expression profile analysis of the hES cell-derived ALB/
mKo1-positive cells
Isolation and analyses of the ALB/mKo1-positive populations
revealed that ALB/mKo1[Hi] populations actively transcribe
ALB compared to ALB/mKo1[Lo] population (Fig. 4A). Through
expression profile analysis of the isolated hES cell-derived ALB/
mKo1[Hi], [Lo], and [−] populations, we found that many
genes responsible for hepatocyte-like characteristics were
up-regulated in the ALB/mKo1[Hi] population as compared
to the ALB/mKo1[−] population (Supplementary Tables
1–5). The liver plays a major role in metabolism (amino
acid synthesis, metabolism of carbohydrates, proteins, and
lipids), iron storage, production of coagulation factors, and
immunological molecules or hormones and is amajor tissue for
drugmetabolism. In addition to producing functional proteins,
nuclear receptors that function as transcription factors and
play regulatory roles are also up-regulated in the ALB/mKo1
[Hi] population as compared to the ALB/mKo1[−] population.
Among the genes that were enriched in the hES-derived ALB/
mKo1[Hi] population, there are many genes in which targeted
mutations in mice resulted in liver phenotypes (Supplementa-
ry Tables 1–3).
Wnt/β-catenin signaling is shown to direct liver metabolic
zonation (Benhamouche et al., 2006; Torre et al., 2011). APC2
gene together with several periportal and perivenous genes
were enriched, and several Wnts are down-regulated in the
ALB/mKo1[Hi] population, thereby suggesting that genes that
play a role in metabolic zonation are actively expressed in
ALB/mKo1[Hi] population (Supplementary Fig. 6).
We also compared our microarray data with other's data
derived from human ES cells H9 and HNF4A knock-down H9
cells (GSE14897 and GSE25417 from GEO, (Si-Tayeb et al.,
2010; DeLaForest et al., 2011)). Of the 297 up-regulated
probe sets in the differentiated H9 cells, 266 probe sets
are not enriched in the ALB/mKo1[Hi] population (Supple-
mentary Fig. 7A). GO terms enriched in these 266 probe
sets are those related to lineages other than the liver,
which are in similarity with our ALB/mKo1 [−] population
(data not shown). By contrast, a high proportion of liver
specific genes (22 out of 28) down-regulated in the HNF4A
knock-down cells are enriched in the ALB/mKo1 [Hi]
population (Supplementary Fig. 7A). We also compared our
microarray profiling results with that of the AFP:eGFP-
positive cells reported previously (Chiao et al., 2008)
(Supplementary Fig. 7B). Approximately1/10 of the 507
probe sets enriched in the AFP:eGFP-positive cells, such as
ALB, transferrinn (TF) and TTR, are overlapped with those
in ALB/mKo1 [Hi]/[−]≥10. Genes, such as CYP3A4, CYP3A7,
HHEX,MAT1A and SERPINA1, are only enriched in ALB/mKo1
[Hi]/[−]≥10. Keratin7 (KRT7) is one of the 460 geneses, of the genes enriched in the ALB/mKo1 [Hi] population. Gene
o1 #5 hES and #24 hiPS were compared with those from #12 hES
#5 hES, #12 hES and #24 hiPS cells. Green: mKO1 fluorescence.
mKO1 (Y-axis) and Hoechst blue (X-axis). Numbers indicate the
mKO1 negative [−], low positive [Lo], and highly positive [Hi]
ere performed in undifferentiated ES cells (ES), mKO1 [−], [Lo],
ts. GAPDH served as a positive control. Scale bars, 100 μm.
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Gene Title Symbol [Hi]/[-] [Lo]/[-]
keratin 19 KRT19 0.5 0.7
keratin 7 KRT7 0.3 0.8
alpha-fetoprotein AFP 3.1 2.3
albumin ALB 25.1 6.7
Figure 7 Cholangiocyte lineage markers Keratin7, Keratin19
and hepatoblast marker AFP expression levels in the three hiPS
cell-derived populations. Keratin 7, 19 are down-regulated, while
AFP, ALB genes are up-regulated in the ALB/mKo1 [Hi] population.
192 K. Umeda et al.specifically enriched in the AFP:eGFP-positive cells, but not
in ALB/mKo1 [Hi]/[−]≥10.
In our present study, AFP is enriched by 3.1- or 2.3-fold in
ALB/mKo1 [Hi]/[−] or [Lo]/[−], respectively. KRT7 or KRT19,
cholangiocyte markers are down-regulated in ALB/mKo1
[Hi]/[−] (Fig. 7). Taken together, the present ALB/mKo1 [Hi]
represents cells of hepatocyte lineage rather than immature
hepatoblast lineage.
As described above, liver specific genes and/or differen-
tially expressed during liver development could be examined
by studying the hES and hiPS cells derived ALB/mKo1-positive
cells. However, besides the genes that are up-regulated in
postnatal livers, some of the genes that are normally down-
regulated in postnatal liver are still expressed in the ALB/
mKo1[Hi]. This result therefore suggests that the differenti-
ated cells are not fully mature and further studies for the
repression of such genes might lead to the derivation of more
matured hepatocytes. Moreover, in spite of many genes
associated with mature hepatocyte are enriched in the ALB/
mKo1[Hi] populations, genes such MRP4 (sinusoidal efflux
transporters), BSEP (canalicular transporters), CYP2C9,
CYP2C19, OATP1B1, and OATP1B3, were not enriched, and
would require further improvement of the differentiation
procedure for obtaining more mature hepatocytes.
OATP1B1 and OATP1B3 are considered to be liver specific
transporters. Targeting of additional reporters into the locus
of these genes in ALB/mKo1 hES/iPS would be helpful for
visualization of further hepatocyte maturation and enable
screening of chemicals that potentiate differentiation. In
this study, we performed targeting to knock-in a mKO1
cassette into ALB gene loci in human ES and iPS cells. The
genetically tagged cells are shown to be valuable for
monitoring in vitro differentiation into hepatic cells, and
allow isolation of cells that actively express ALB at a
transcriptional but not translational level. Analysis of
the ALB/mKo1-positive cells revealed that cells activelytranscribing ALB correlate to their ability to express
characteristic marker genes of the adult human hepato-
cytes. Similar enrichments of the characteristic marker
genes in ALB/mKo1 [Hi] populations were confirmed in
different knock-in clones established in this study (Fig. 6).
Our results therefore reinforced the advantage of using
the present ALB/mKo1 knock-in hES/iPS cell lines for gaining
further insights into the differentiation and characterization
of hES/iPS cell-derived hepatocytes.Acknowledgments
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